anidulafungin

Azole-echinocandin Combination Therapy for Invasive Aspergillosis

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment

Negative Beta Glucan in ICU Patients

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients

Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

Anidulafungin in Treating Immunocompromised Children With Neutropenia

Anidulafungin PK in Infants and Toddlers

Antimicrobial PK in Infants With Suspected or Confirmed Infection

Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Anidulafungin in Patients With Hematologic Malignancies

Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)

The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis